Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Safety and Efficacy of Xalkori ROS1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Directly Observed and Long-term Varenicline
- Status
- COMPLETED
- Phase
- PHASE4
PF-06741086 Long-term Treatment in Severe Hemophilia
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4
Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation
- Status
- UNKNOWN
- Phase
- PHASE3
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
- Status
- COMPLETED
- Phase
- PHASE4
Staphylococcus Aureus Surgical Site Infection Multinational Epidemiology in Europe
- Status
- COMPLETED
- Phase
- N/A
Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2